Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Medtronic’s Neurovascular business unit received U.S. FDA clearance of the Riptide(TM) Aspiration System

New System Expands Neurovascular Product Portfolio for the Treatment of Acute Ischemic Stroke DUBLIN, 17-Jan-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced that the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, … Read the full press release

Shire CMO Howard Mayer, M.D.: no patient is currently being denied access to treatment with Hemlibra

DUBLIN, 16-Jan-2018 — /EuropaWire/ — At Shire, we’ve been committed to the hemophilia community and the lives of every patient afflicted with this disease for more than 70 years. We are very proud of this legacy and take our role as … Read the full press release

Shire: EU approval of ADYNOVI is an important milestone in our continued commitment to provide new treatment options for patients with hemophilia A

Marketing Authorization will enable patient access to ADYNOVI throughout Europe ZUG, 16-Jan-2018 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare diseases, announced today that the European Commission (EC) has granted Marketing Authorization for ADYNOVI … Read the full press release

Nanodomains: Universities of Exeter, Leeds and Cambridge researchers unveils new method to gain a greater understanding of signalling stations within the cells

EXETER, 15-Jan-2018 — /EuropaWire/ — The complex and mysterious mechanisms that drive communication and reactions within human cells could be on the verge of being unravelled, due to a pioneering new technique. Researchers from the Universities of Exeter, Leeds and Cambridge … Read the full press release

Allianz announces $59.2 million investment and strategic partnership with American Well to develop global telehealth system

Allianz X invests in telehealth solutions leader American Well and joins Board of Directors Allianz and American Well to develop digital solutions that broaden access to quality healthcare American Well will leverage Allianz’s global expertise to internationalize their state-of-the-art digital … Read the full press release

Novartis: US FDA grants Breakthrough Therapy designation to Promacta® (eltrombopag) for the treatment of patients with SAA

Data supporting designation showed over half of treatment-naïve SAA patients achieved complete response with Promacta when given with standard immunosuppressive therapy, with overall response rate of 85%[1] Promacta is the only TPO receptor agonist indicated for the treatment of patients … Read the full press release

Technical University of Munich (TUM): Multiple sclerosis: Cholesterol crystals can trigger chronic inflammation that in turn impedes regeneration in the central nervous system

  MUNICH, 09-Jan-2018 — /EuropaWire/ — Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system, in which the body’s own immune cells attack the fatty, insulating myelin sheath surrounding nerve fibers. The regeneration of intact myelin … Read the full press release

University of Warwick: biotechnology firm VirionHealth receives non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA)

Coventry, UK, 08-Jan-2018 — /EuropaWire/ — VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has won non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA). … Read the full press release

Barco receives “Supplier of the Year for 2017” award by Agfa HealthCare

Barco, a global leader in healthcare imaging, has received the prestigious “Supplier of the Year for 2017” award bestowed annually by Agfa HealthCare, a leading provider of eHealth and digital imaging solutions. Cutting-edge diagnostic imaging focused on enabling better patient … Read the full press release

TU Delft researchers have developed a hybrid meta-biomaterial that promotes bone growth

Delft, Netherlands, 05-Jan-2018 — /EuropaWire/ — It is not something you will find in nature, but it can be created using a 3D printer and existing biomaterials: a hybrid meta-biomaterial that promotes bone growth. TU Delft researchers have developed a meta-implant … Read the full press release

Shire plc files its first submission to the US FDA for its new plasma manufacturing facility in Covington, GA

DUBLIN, 02-Jan-2018 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare diseases, today announced that it has filed its first submission to the United States Food and Drug Administration for the company’s new plasma manufacturing … Read the full press release

LMU researchers put a spotlight on the smallest blood cells known as platelets

MUNICH, 29-Dec-2017 — /EuropaWire/ — A new study by medical researchers at LMU extends the list of tasks performed by the smallest blood cells known as platelets: At sites of infection, actively migrating platelets sweep bacteria into aggregates for disposal by … Read the full press release

New substance discovered against life-threatening tuberculosis infections

MUNICH, 29-Dec-2017 — /EuropaWire/ — In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They … Read the full press release

Royal Philips installs world’s first and only fully digital PET/CT system in the Clinique de Genolier, Switzerland

Amsterdam, the Netherlands and Genolier, Switzerland, 28-Dec-2017 — /EuropaWire/ — Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced the successful installation of its Vereos digital PET/CT system, the world’s first and only fully digital PET/CT … Read the full press release

LUXEMBOURG INSTITUTE OF HEALTH: Dr Jonathan Turner, Prof Muriel Darnaudery, and Prof Jamileh Movassat to receive funding in the ANR-FNR call for research project in epigenetics

LUXEMBOURG, 20-Dec-2017 — /EuropaWire/ — In September 2017, the Luxembourg National Research Fund (FNR) announced the bilateral research projects that will be funded jointly by FNR and the “Agence Nationale de la Recherche” (ANR) in France from the INTER call 2017. … Read the full press release

New CERN-MEDICIS facility produces its first radioisotopes for medical research to diagnose cancers

GENEVA, 14-Dec-2017 — /EuropaWire/ — Today (12 Dec 2017), the new CERN-MEDICIS facility has produced radioisotopes for medical research for the first time. MEDICIS (Medical Isotopes Collected from ISOLDE) aims to provide a wide range of radioisotopes, some of which can … Read the full press release

EURORDIS and its members launch new position paper calling for urgent change to improve patients’ access to rare disease therapies in Europe

PARIS, 13-Dec-2017 — /EuropaWire/ — EURORDIS and its over 700 member patient organisations have launched a new position paper calling for urgent change to ensure patients’ full and fast access to rare disease therapies in Europe. The ‘Breaking the Access Deadlock to … Read the full press release

Sampo donates in support of cancer research in Finland

HELSINKI, 12-Dec-2017 — /EuropaWire/ — Sampo plc’s annual Christmas donation will be given this year to the Cancer Foundation, which supports cancer research in Finland. The donated amount is EUR 10,000. The Cancer Foundation supports basic and clinical cancer research. The … Read the full press release

University of Twente: Gréanne Leeftink will be awarded a PhD for her thesis entitled: Why Wait? – Organizing integrated processes in cancer care

ENSCHEDE, the NETHERLANDS, 11-Dec-2017 — /EuropaWire/ — In the Netherlands, first-rate care pathways have been developed for various types of cancer. The only drawback is that patients cannot receive the full benefit of this care if they have to wait – … Read the full press release

Professor Mick Peake honoured by the Irish Cancer Society for his lifelong work in cancer research

Professor Mick Peake recognised for lifelong work in cancer research and care LEICESTER, 11-Dec-2017 — /EuropaWire/ — A University of Leicester Professor and consultant at Leicester’s Hospitals has been honoured ‘for his lifelong work on earlier diagnosis and improved outcomes for … Read the full press release

The Leicester Diabetes Centre (LDC) recognised by the International Diabetes Federation (IDF)

LEICESTER, 11-Dec-2017 — /EuropaWire/ — A diabetes research centre based in Leicester has officially been recognised for its “high global standards” by an international authority on the condition The Leicester Diabetes Centre (LDC) has been named an ‘International Centre of … Read the full press release

University of Bristol: discovery on how cells rebuild after division could have major implications for understanding cancer and degeneration

BRISTOL, 07-Dec-2017 — /EuropaWire/ — University of Bristol research has revealed how cells rebuild their nucleus and organise their genome when they divide – a discovery which could have major implications for understanding cancer and degeneration. When cells divide, they need … Read the full press release

Sanofi’s Toujeo® met primary objective in the first head-to-head clinical trial comparing Toujeo with insulin degludec

First head-to-head randomized clinical trial comparing the efficacy and safety of Toujeo (insulin glargine 300 Units/mL) versus insulin degludec PARIS, 05-Dec-2017 — /EuropaWire/ — Sanofi’s Toujeo® met the primary study objective in the first large head-to-head clinical trial1, called BRIGHT study, … Read the full press release

Sanofi discontinues clinical development of its experimental Clostridium difficile vaccine

PARIS, 05-Dec-2017 — /EuropaWire/ — Following a planned interim analysis, the Independent Data Monitoring Committee (IDMC) for the phase III Cdiffense clinical trial program concluded that the probability that the study will meet its primary objective is low. Based on this, Sanofi has … Read the full press release

University of Zurich researchers awarded ERC Consolidator Grants

ZURICH, 05-Dec-2017 — /EuropaWire/ — Two researchers from the University of Zurich have been awarded lucrative Consolidator Grants: The European Research Council has awarded funds to Prof. Daniel Moeckli, whose research focuses on the interplay between people’s sovereignty and the rule … Read the full press release

200 healthcare decision-makers gather to address the looming challenges of cost, access and sustainability in the coming wave of high-value medicines

LONDON, 01-Dec-2017 — /EuropaWire/ — On December 5-6, 2017, 200 high-level experts from government, academia, biopharmaceutical developers and patient organisations convene in London (UK) to address the mounting challenge of accessibility and patient access to high-value, high-cost medical therapies. The … Read the full press release

GSK: NDA submission to US FDA for single-dose tafenoquine for the radical cure of Plasmodium vivax malaria

Regulatory milestone affirms GSK’s strong commitment and scientific capabilities to fighting infectious diseases  LONDON/GENEVA, 29-Nov-2017 — /EuropaWire/ — GSK and Medicines for Malaria Venture (MMV) today announced the submission of a new drug application (NDA) by GSK to the United States … Read the full press release

GSK on UK Government’s Industrial Strategy: Meaningful targets, sustained efforts and coherent implementation will be critical to this strategy’s success

LONDON, 29-Nov-2017 — /EuropaWire/ — Responding to the launch of the Industrial Strategy White Paper, published today by the UK Government, Phil Thomson, President, Global Affairs, at GSK said: “A new, long-term industrial strategy for the country is important and welcome. We … Read the full press release

ViiV Healthcare begins phase III study on long-acting two-drug regimen in virally suppressed adults with HIV-1 infection

The ATLAS-2M study will evaluate injections every two months in virally suppressed patients LONDON, 29-Nov-2017 — /EuropaWire/ — Today (27 November 2017) ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, … Read the full press release

GSI receives green light for continuing radon therapy research with €4 million funding

Darmstadt, GERMANY, 24-Nov-2017 — /EuropaWire/ — A multi-year research project led by the GSI Helmholtzzentrum für Schwerionenforschung has been investigating the anti-inflammatory therapeutic effect, as well as the risks, of treatment with the inert gas radon. The project has now received … Read the full press release